Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.112649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Arjun Kharel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Hauptthemen laut MEDLINE: Melanoma, Virus Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
During chronic viral infection and cancer, it has been established that a subset of progenitor CD8+ T cells continuously gives rise to terminally exhausted cells and cytotoxic effector cells. Although multiple transcriptional programs governing the bifurcated differentiation trajectories have been previously studied, little is known about the chromatin structure changes regulating CD8+ T cell-fate decision. In this study, we demonstrate that the chromatin remodeling complex PBAF restrains expansion and promotes exhaustion of CD8+ T cells during chronic viral infection and cancer. Mechanistically, transcriptomic and epigenomic analyses reveal the role of PBAF in maintaining chromatin accessibility of multiple genetic pathways and transcriptional programs to restrain proliferation and promote T cell exhaustion. Harnessing this knowledge, we demonstrate that perturbation of PBAF complex constrained exhaustion and promoted expansion of tumor-specific CD8+ T cells resulting in antitumor immunity in a preclinical melanoma model, implicating PBAF as an attractive target for cancer immunotherapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
- Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Blood Research Institute, Versiti, Milwaukee, WI, USA; Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
- Blood Research Institute, Versiti, Milwaukee, WI, USA.
- Blood Research Institute, Versiti, Milwaukee, WI, USA; Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- American Cancer Society
- National Institute of General Medical Sciences
Zitieren
APA
Kharel, A., Shen, J., Brown, R., Chen, Y., Nguyen, C., Alson, D., Bluemn, T., Fan, J., Gai, K., Zhang, B., Kudek, M., Zhu, N., & Cui, W. (2023). Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112649
Vancouver
Kharel A, Shen J, Brown R, Chen Y, Nguyen C, Alson D, et al. Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112649
BibTeX
@article{Kharel2023,
author = {Kharel, Arjun and Shen, Jian and Brown, Ryan and Chen, Yao and Nguyen, Christine and Alson, Donia and Bluemn, Theresa and Fan, Jie and Gai, Kexin and Zhang, Bin and Kudek, Matthew and Zhu, Nan and Cui, Weiguo},
title = {Loss of PBAF promotes expansion and effector differentiation of CD8+ T cells during chronic viral infection and cancer},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.112649}
}
EUVIMED